Companies / Tandem Diabetes Care Inc
Tandem Diabetes Care Inc
Financials · FY2025
Ownership
69.6M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.56% | 392,799 |
| 10%+ / strategic | 4.15% | 2,889,691 |
| Institutions | 106.24% | 73,923,908 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 10
View all →| Insider | % of shares | Shares |
|---|---|---|
Sheridan John FCEOPRESIDENT & CEO · Director | 0.22% | 152,443 |
Morrison SusanEVP & Chief Admin. Officer | 0.06% | 42,635 |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER | 0.06% | 39,411 |
Novara Mark DavidEVP & CHIEF COMMERCIAL OFFICER | 0.05% | 37,656 |
Carpenter RickChief Technology Officer | 0.04% | 25,274 |
Twomey Christopher JDirector | 0.04% | 24,434 |
Kyrillos Jean-ClaudeEVP & Chief Operating Officer | 0.03% | 24,062 |
Hansen Shannon MarieEVP & Chief Legal Officer | 0.03% | 23,276 |
Robertson Rebecca BDirector | 0.03% | 22,542 |
Gasser Elizabeth AnneEVP, Chief Strategy Officer | <0.01% | 1,066 |
Institutional holders 274
View all →| Holder | Value | % of shares |
|---|---|---|
| $174.79M | 16.65% | |
| $161.36M | 10.55% | |
| $109.90M | 7.19% | |
| $63.52M | 4.15% | |
| $45.91M | 3.00% | |
| $45.73M | 2.99% | |
| $45.67M | 2.99% | |
| $44.43M | 2.91% | |
| $43.03M | 4.10% | |
| $37.00M | 2.42% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | Sheridan John F CEO | Other | Common Stock | $242.9K | -19K -11.14% | 151,107 0.22% of shares | low |
| Mar 16, 2026 | Novara Mark David Executive | Other | Common Stock | $119.6K | -6K -12.77% | 37,843 0.05% of shares | low |
| Feb 17, 2026 | Sheridan John F CEO | Other | Common Stock | $45.5K | -2K -1.89% | 124,691 0.18% of shares | low |
| Jan 15, 2026 | Kyrillos Jean-Claude Executive | Other | Common Stock | $44.6K | -2K -8.09% | 24,062 0.03% of shares | low |
| May 15, 2026 | Sheridan John F CEO | Other | Common Stock | $39.0K | -3K -2.28% | 130,316 0.19% of shares | low |
| Feb 17, 2026 | Sheridan John F CEO | Other | Common Stock | $37.2K | -2K -1.59% | 121,108 0.17% of shares | low |
| May 15, 2026 | Sheridan John F CEO | Other | Common Stock | $35.7K | -3K -2.14% | 127,378 0.18% of shares | low |
| Feb 17, 2026 | Gasser Elizabeth Anne Executive | Other | Common Stock | $16.8K | -887 -59.02% | 616 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| ArrowMark Colorado Holdings, LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| TNDM | — | 875372203 |